Topics in Anti-Cancer Research covers new developments in the field of cancer diagnosis and drug therapy. Novel drugs as anticancer agents include natural and synthetic phenazirines and other anti-cancer compounds. The series also covers information on the current understanding of the pathology and molecular biology of specific neoplasms.
The diversity of research topics published in this book series give broad and valuable perspectives for cancer researchers, clinicians, cancer professionals aiming to develop novel anti-cancer targets and patents for the treatment of various cancers.
The topics covered in ninth volume are:
- Recent Patents on Exosome-Derived Therapeutic Agents
- Serrated Lesions of the Colon and Rectum: An Overview of Pathology and Emphasis on a New Classification
- Introducing the 188W/188Re and 144Ce/144Pr Plaques for Eye Cancers Brachytherapy
- ShcA Family of Adaptor Proteins: Dual Role in Cell Growth
- Hormones Management as Anticancer Treatment and Protection: Functions and Mechanism of Action
About the Editor:
Prof. Atta-ur-Rahman, Ph.D. in Organic Chemistry from Cambridge University (1968) has 1,232 international publications (45 international patents and 341 books). He received the following awards: Fellow Royal Society (FRS) London (2006), UNESCO Science Prize (1999), Honorary Life Fellow Kings College, Cambridge University (2007), Academician (Foreign Member) Chinese Academy of Sciences (2015), Highest Civil Award for Foreigners of China (Friendship Award, 2014), High Civil Award Austria ("Grosse Goldene Ehrenzeischen am Bande") (2007), Foreign Fellow Chinese Chemical Society (2013), Sc.D. Cambridge University (UK) (1987), TWAS (Italy) Prize (2009). He was the President of Network of Academies of Sciences of Islamic Countries (NASIC), Vice President TWAS (Italy), Foreign Fellow Korean Academy of Science & Technology, President Pakistan Academy of Sciences (2003-2006) and (2011 -- 2014). He was the Federal Minister for Science and Technology of Pakistan (2000 -- 2002), Federal Minister of Education (2002) and Chairman Higher Education Commission/Federal Minister (2002-2008), Coordinator General of COMSTECH (01C Ministerial Committee) (1996-2012), and the Editor-in-Chief of Current Medicinal Chemistry.
Cancer, molecular biology, neoplasms, drug therapy, Anticancer Treatment, Cell Growth, Pathology, cancer research
For further information, please visit: http://bit.